Gateway to Weight Gain Study
The Nutrition and CF research teams need patients and families who will be starting Kalydeco ivacaftor)
for a study looking at the causes of weight gain with Kalydeco treatment in people with Cysric Fibrosis and a gating mutation.
This study will assess change in energy balance, weight, muscle, fat, and lung function in subjects 6 and older
with any of the gating mutations before Kayldeco treatment and after three months. All subjects will be seen at
the Children’s Hospital of Philadelphia Clinical Translational Research Center.
You can download a PDF of it by clicking
on the picture below:
For additional information, please see our study flyer, or contact: